In a randomised trial of artificial surfactant (ALEC) given at birth to 294 babies less than 34 weeks' gestation, the respiratory compliance was measured at 1, 6, 24, 48, and 168 hours after birth. In babies less than 29 weeks' gestation ALEC significantly improved the mean (SEM) compliance at 6 hours from 0.54 (0.06) to 0-91 (0-13) ml/cm H20/kg and at 24 hours from 0.57 (0-04) to 092 (0-10) ml/cm H20/kg. The improvements at 1, 48, and 168 hours were not significant. In babies of over 29 weeks' gestation the compliance was lower in the ALEC treated babies. This was significant only at one hour: 0.52 (0.03) compared with 0-71 (0.07) ml/cm H20/kg and only occurred in babies who were not ventilated. Experiments to assess the effect of ALEC on respiratory compliance in premature rabbits at 27 days' gestation showed that it significantly improved the compliance after one hour's ventilation from 0 07 to 0-27 ml/cm H20/kg (p<0 05) and after one hour's spontaneous breathing from 0-10 to 0-58 ml/cm H20/kg.5
Several randomised trials have shown that surfactant treatment of premature babies improves their oxygenation and ventilation. Only one has reported the effect of surfactant treatment on pulmonary mechanics in non-randomised babies. ' This paper reports measurements of the respiratory compliance made during a randomised trial of artificial surfactant given at birth to babies under 35 weeks' gestation. The surfactant, called artificial lung expanding compound (ALEC, Pumactant, Britannia Pharmaceuticals) is a protein free mixture of two pure phospholipids. The formulation, properties, and details of the trials have been described.'
Experiments to assess the effect of ALEC on respiratory compliance in premature rabbits at 27 days' gestation showed that it significantly improved the compliance after one hour's ventilation from 0 07 to 0-27 ml/cm H20/kg (p<0 05) and after one hour's spontaneous breathing from 0-10 to 0-58 ml/cm H20/kg.5
When ALEC was given prophylactically to babies less than 30 weeks' gestation, it significantly reduced the inspired oxygen concentration and ventilator pressure requirements in the first few days. It also significantly reduced the time babies required artificial ventilation, the time they were treated with more than 300/o oxygen, the mortality, and the incidence of intracerebral haemorrhage.2 4 6 Accurately measuring respiratory compliance in ill premature babies is difficult. Respiratory compliance was related to birth weight but not to length because it is difficult to measure in small sick babies.
Compliance was calculated from the recordings of 10 breaths without artifacts.
Dynamic compliance Dynamic compliance was calculated for those babies who were breathing spontaneously. In intubated babies tidal volume and oesophageal pressure were measured during a brief disconnection from the ventilator. The pressure difference for this calculation was taken from the airway pressure at points of zero air flow. Expiratory volumes were used for calculations of tidal volume to minimise any error from leakage around the uncuffed endotracheal tube. In nonintubated babies the pneumotachograph was attached to a closely fitting face mask and recordings of tidal volume and oesophageal pressure were made when the baby was quiet and the face mask leak free (the inspiratory and expiratory volumes were equal).
Static compliance Static compliance measurements were only made when babies were apnoeic or paralysed with pancuronium. The respiratory compliance was calculated from the tidal volume and the applied ventilator pressure difference measured accurately from a recording of the waveform. Tidal volume was-measured when the inflating pressure had been held for at least 0-5 seconds and the volume exchange had reached a plateau.
Reproducibility of compliance measurements
The reproducibility of both static and dynamic compliance was tested in 20 infants whose clinical condition remained stable over several hours (assessed by lack of change in blood gas values and ventilator settings). Compliance measurements were made at 0, 30, 60, 120, 180, and 360 minutes. The intrasubject coefficient of variation was 22-3% for static compliance and 30 3% for dynamic compliance. The apparent variability of the measurement may be explained by the relatively long period over which measurements were made. More frequent measurements in such fragile babies would have been inappropriate. MISSING 
DATA
Of 1405 occasions when compliance should have been measured satisfactory recordings were obtained on 777. Measurements were not possible on the other occasions for a number of reasons: the equipment was faulty or being serviced (n=353), the research staff were unavailable (n=52), the baby had died (n=31), or had been transferred out of the unit (n=67). In addition, from baby 140 onwards no six hour measurements were made because of logistic difficulties with trying to make three recordings in 24 hours.
The number of compliance measurements for each treatment group are shown in table 2 as a percentage of the babies who were alive and eligible for measurements at each time. Table 3 shows the number of ventilated babies measured at each time and their percentage of the recordings made. The proportions in the two groups are not significantly different. with respiratory distress syndrome because they actively expire during the obstruction.'5 Spontaneously breathing babies with lung disease have retraction of the chest wall during inspiration'7; this reduces the tidal volume for an inspiratory force. The magnitude of the retraction depends on the gestation, the severity of lung disease, the strength of the diaphragmatic contraction, the baby's position and sleep state. If dynamic compliance is measured during disconnection from the ventilator lung volume may fall because the larynx is bypassed by the endotracheal tube.
Results
The validity of the dynamic compliance measurements also depends on accurately recording oesophageal pressure. Unfortunately, this measurement may be inaccurate because the oesophageal pressure in very premature babies varies from the cardiac sphincter to the thoracic inlet and accurate, consistent placement of the oesophageal balloon is difficult.7 Traditional methods of assessing the accuracy of oesophageal pressure measurements are not possible or useful in ventilated infants.9 Leaks around the endotracheal tube can prevent complete airway occlusion and where occlusion is possible it is Despite possible difficulties with respiratory compliance measurements, our results are comparable with those found by others in premature infants of similar weight. 19 20 Thus despite relatively high coefficients of variation, this suggests our techniques were as accurate as those used by others. In physiological studies designed to measure respiratory compliance it is possible to control for many of the factors that affect compliance. This is rarely possible in clinical studies. This paper reports comparisons between two randomised groups of ill premature babies who were well matched, apart from surfactant treatment, for the factors that might influence respiratory compliance. As described it was not always possible to measure the respiratory compliance because of equipment failure, neonatal deaths, discharges, or technical difficulties. However, these data losses affected both ALEC treated and control babies to a similar extent. It is therefore valid to compare the overall results from the two groups.
It is possible that saline instilled into the trachea may have altered the respiratory compliance. 21 Any effect of instilling saline would not affect the comparison between the two groups, however, because ALEC was suspended in exactly the same volume of saline as was given to the control babies. Both groups therefore received identical volumes of saline. This volume was used because it was the volume that was considered to be safe for routine endotracheal suction.
This study has shown that artificial surfactant (ALEC) given at birth to babies between 23 and 29 weeks' gestation improves respiratory compliance during the first hours of life so that by 6 Milner et al measured compliance at resuscitation in a group of intubated babies after they had received one dose of ALEC, and before and immediately after they were given a second dose, and showed no apparent effect. 24 The results of their measurements are not at variance with this study and again suggest that ALEC takes a few hours to produce its maximum effect after administration at birth.
ALEC had no beneficial effect on the compliance of babies of 30-34 weeks' gestation. The compliance was significantly lower at the one hour measurement in the surfactant treated babies. Many babies in this gestational age group were not very ill. A minority were ventilated and most of those were ventilated for less than one day. Thirty percent did not receive any oxygen, and of those that did receive oxygen 70% had it for less than 72 hours. Exploring the data showed that this effect was present only in babies who were not ventilated. This difference was not seen in the babies less than 30 weeks possibly because most were intubated and ventilated from birth. A possible interpretation of this finding is that surfactant should only be given to those babies who require intubation and ventilation at birth. It is possible that positive pressure ventilation distributes the surfactant to the periphery of the lung whereas in spontaneously breathing babies substantial amounts may remain in the large airways and increase their resistance.
In a non-randomised study Davis et al measured respiratory mechanics after administration of calf surfactant extract to premature babies with established respiratory distress syndrome.1 In 10 ventilated babies, despite improvement in gas exchange, no significant improvement in pulmonary mechanics could be demonstrated. In 25 infants who were only receiving continuous positive airways pressure there was an improvement in compliance.
The artificial surfactant ALEC given at birth to babies under 30 weeks' gestation improves the compliance of the respiratory system by 6 hours of age. This improvement in lung function reflects the lower incidence of respiratory distress syndrome, lower oxygen and ventila-tory requirements, and reduced mortality seen in babies treated with this artificial surfactant. This simple, protein free surfactant should be a useful addition to the therapeutic weapons of the neonatologist in babies of this age.
Favouritism and child abuse Social and cultural differences between nations may make it unsafe to generalise from data derived from one country. Nevertheless a paper from Japan (Tanimura et al, Lancet 1990; 336:1298-9) provides food for thought about child abuse and there seems to be no a priori reason why the findings shoud not be generally applicable. One in 10 abused children in a national survey were from multiple births, 15 times the expected rate. In 80% of cases where a twin was abused the other twin was not. The factors leading to abuse for both twins or of only one were different. Abuse of both twins was associated with social, economic, and marital problems and personality disorder in the parents. When one twin was abused that twin was likely to be chronically ill or to have been separated from the parents for a long time, though parental problems were still common. The parents often admitted a strong preference for the other child.
The findings suggest that a potent combination leading to child abuse is parental stress together with some 'unlovable' feature in the child leading to favouritism. Health professionals must be alert to this and the even more important possibility that appropriate intervention might redress the balance and prevent abuse, in singletons as well as in twins.
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